Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HELIX BIOPHARMA (HBP:TSE) -- Ignore unavailable to you. Want to Upgrade?

To: thewiz who wrote (175)	3/16/1999 11:04:00 AM
From: burner	Respond to of 193

No news yet. The company is trading where it should be in my opinion. The company is more focussed now on its drug delivery development and if they can achieve what they want to, with some notoriety, they company could hit big time when a major pharmaceutical enters the picture. Dan Byrne

To: thewiz who wrote (175)	3/16/1999 10:24:00 PM
From: burner	Respond to of 193

Wiz, No news yet. There was a related item concerning Terry Owen (former pres) commenting on gov't subisidies but nothing that could impact the stock. My guess is that Investor Relations is getting the word out that company plans are working, and milestones are inevitable. One patent has been received and another is getting closer to be issued. Scientific results are progressing with work continuing on insulin and interferon data to be interpreted in 3 months. Discussions with potential partners are looking as though something may develop. A confiedntiality agreement is already in place. Sensium on its way to becoming self funded. Quarterly results may be out very soon and wouldn't it be nice it they were substantially improved? regards, Dan